HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 268 filers reported holding HAEMONETICS CORP in Q3 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $222,000 | -50.8% | 2,010 | -47.1% | 0.00% | -50.0% |
| Q4 2020 | $451,000 | +68.3% | 3,798 | +23.4% | 0.00% | +100.0% |
| Q3 2020 | $268,000 | -20.0% | 3,077 | -8.6% | 0.00% | -50.0% |
| Q1 2020 | $335,000 | -31.2% | 3,367 | -20.4% | 0.00% | 0.0% |
| Q4 2019 | $487,000 | -6.5% | 4,232 | +2.5% | 0.00% | -33.3% |
| Q3 2019 | $521,000 | +23.5% | 4,129 | +17.8% | 0.00% | +50.0% |
| Q2 2019 | $422,000 | -11.7% | 3,504 | -76.3% | 0.00% | -33.3% |
| Q3 2015 | $478,000 | -68.8% | 14,810 | -60.0% | 0.00% | -66.7% |
| Q2 2015 | $1,531,000 | -27.7% | 37,004 | -21.6% | 0.01% | -30.8% |
| Q1 2015 | $2,119,000 | +3.7% | 47,174 | -13.6% | 0.01% | 0.0% |
| Q4 2014 | $2,043,000 | +6.0% | 54,582 | -1.1% | 0.01% | +8.3% |
| Q3 2014 | $1,928,000 | +108.7% | 55,212 | +110.9% | 0.01% | -69.2% |
| Q2 2014 | $924,000 | +8.3% | 26,180 | 0.0% | 0.04% | +11.4% |
| Q1 2014 | $853,000 | -22.7% | 26,180 | 0.0% | 0.04% | -23.9% |
| Q4 2013 | $1,103,000 | – | 26,180 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |